Influence Factors on Contrast Agent Venous Intravasation During Transvaginal 4‐Dimensional Hysterosalpingo‐Contrast Sonography

Wang, Weiqun; Zhou, Qiulan; Zhou, Xingxing; Chen, Zhiyi; Zhang, Hui

doi:10.1002/jum.14594

Cited by 16 publications

(37 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In this study, unlike the report by Wang et al (2018), a higher venous intravasation rate occurs at 3À4 d after the menstrual cycle, not 8À9 d. In HSG, intravasation was higher during postmenstrual (3À5 d) and preovulatory (11À13 d) than during middle follicular stage (6À10 d) (Dusak et al 2013). Histopathologic studies have shown Type A = The tube was patent, and the contrast agent flowed smoothly through it.…”

Section: Discussioncontrasting

confidence: 63%

“…This phenomenon was has been referred to as "venous intravasation," which is a well-described complication during HSG and hysteroscopy (Bradley 2002;Chang and Shim 2012;Dusak et al 2013). The incidence of intravasation was 13.04%À41.3% in TV 4-D HyCoSy (Liang et al 2015;Wang et al 2018), which was much higher than that in HSG (0.4%À7.2%; Dusak et al 2013;Gowin et al 1984;Nunley et al 1987). Venous intravasation would affect the observation of fallopian tube development and pelvic cavity diffusion, leading to the difficulty in distinguishing them from intravasation.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

The Influencing Factors of Venous Intravasation During Transvaginal Four-dimensional Hysterosalpingo-contrast Sonography With SonoVue

Shi

et al. 2019

Ultrasound in Medicine & Biology

View full text Add to dashboard Cite

Transvaginal 4-D hysterosalpingo-contrast sonography with SonoVue (TV 4-D HyCoSy) is the preferred imaging method for evaluating tubal patency. However, venous intravasation in 4-D HyCoSy may affect the diagnosis of tubal patency. The objective of this study was to analyze influencing factors of venous intravasation during TV 4-D HyCoSy. This study included 643 infertile patients who underwent TV 4-D HyCoSy. We analyzed the relationship between the incidence of venous intravasation and patients' basic clinical data, endometrial thickness, inspection timing (clean day of menstruation) and tubal patency. A total of 169 (26.28%) patients exhibited intravasation during TV 4-D HyCoSy. The following are risk factors for venous intravation: secondary infertility, type C + C, type B + C and type B + B in bilateral fallopian tubal patency grouping; endometrial thickness 5.45 mm; and taking TV 4-D HyCoSy after menstruation 6 d. Infertility duration, intrauterine lesions, a history of pelvic inflammatory disease and a history of pelvic surgery were uncorrelated with venous intravasation. To reduce the incidence of venous intravasation, TV 4-D HyCoSy should be performed 7À10 d after menstruation or when endometrial thickness is thicker than 5.45 mm.

show abstract

Section: Discussioncontrasting

confidence: 63%

Section: Introductionmentioning

confidence: 99%

The Influencing Factors of Venous Intravasation During Transvaginal Four-dimensional Hysterosalpingo-contrast Sonography With SonoVue

Shi

et al. 2019

Ultrasound in Medicine & Biology

View full text Add to dashboard Cite

show abstract

“…Firstly, venous intravasation occurs in approximately 2–7% of cases undergoing HSG and seems to occur more frequently when using oil‐based contrast medium. Some reports on venous intravasation during ultrasound show a higher incidence (13%). While intravasation can potentially result in life‐threating pulmonary embolism, we are unaware of any deaths reported since the 1960s.…”

Section: Discussionmentioning

confidence: 81%

Effectiveness on fertility outcome of tubal flushing with different contrast media: systematic review and network meta‐analysis

Wang

Welie

Rijswijk

et al. 2019

Ultrasound in Obstet & Gyne

View full text Add to dashboard Cite

Objectives To compare, in women with infertility, the effectiveness and safety of tubal flushing using oil-based contrast medium, water-based contrast medium or their combination, and no tubal flushing, and to evaluate the effectiveness of tubal flushing on fertility outcome over time. MethodsWe performed a systematic review and network meta-analysis, searching the electronic databases MEDLINE, EMBASE and Cochrane Central Register of Controlled Trials, and trial registries, up to 25 September 2018. We included randomized controlled trials (RCTs) comparing the following interventions with each other or with no intervention in women with infertility: tubal flushing using water-based contrast medium, tubal flushing using oil-based contrast medium or additional tubal flushing with oil-based medium following diagnostic tubal flushing with water-based medium. The outcomes included clinical pregnancy, live birth, ongoing pregnancy, miscarriage, ectopic pregnancy and adverse events. ResultsOf the 283 studies identified through the search, 14 RCTs reporting on 3852 women with infertility were included. Network meta-analysis showed that tubal flushing using oil-based contrast medium was associated with higher odds of clinical pregnancy within 6 months after randomization and more subsequent live births compared with tubal flushing using water-based medium (odds ratio (OR), 1.67 (95% CI, 1.38-2.03), moderate certainty of evidence ; and OR, 2.18 (95% CI,, ConclusionsIn women with infertility undergoing fertility workup, tubal flushing using oil-based contrast medium probably increases clinical pregnancy rates within 6 months after randomization and may increase subsequent live-birth rates, compared with tubal flushing using water-based contrast medium and compared with no intervention. Evidence on fertility outcomes beyond 6 months is inadequate to draw firm conclusions.

show abstract

“…106 After the first report, a cascade of studies were published regarding intravasation during HyCoSy with SonoVue, showing the rate of intravasation between 13 and 26%. 107,108 It means that observers were not familiar with this event and how to recognize it earlier.…”

Section: Safety Hysterosalpingographymentioning

confidence: 99%

Tubal Flushing Treatment for Unexplained Infertility

et al. 2020

View full text Add to dashboard Cite

Tubal patency testing was initially introduced as a diagnostic test. However, it has been observed that some tubal patency tests also have a therapeutic effect. This therapeutic effect can be influenced by the contrast medium used during tubal flushing. In this review, we discuss current evidence associated with different methods for tubal flushing and their potential impact on reproductive outcomes in women with unexplained infertility. Furthermore, we discuss their diagnostic accuracy, safety, and cost-effectiveness.

show abstract

Influence Factors on Contrast Agent Venous Intravasation During Transvaginal 4‐Dimensional Hysterosalpingo‐Contrast Sonography

Abstract: Contrast agent intravasation during TVS 4D-HyCoSy is not infrequent. Performing TVS 4D-HyCoSy according to endometrial thickness and menstrual period could reduce intravasation incidence to some extent.

Cited by 16 publications

References 13 publications

The Influencing Factors of Venous Intravasation During Transvaginal Four-dimensional Hysterosalpingo-contrast Sonography With SonoVue

The Influencing Factors of Venous Intravasation During Transvaginal Four-dimensional Hysterosalpingo-contrast Sonography With SonoVue

Effectiveness on fertility outcome of tubal flushing with different contrast media: systematic review and network meta‐analysis

Tubal Flushing Treatment for Unexplained Infertility

Contact Info

Product

Resources

About